Not even close, moron, the abortion issue has already been

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks Steel Reserve #116432
197
Not even close, moron, the abortion issue has already been test driven to great success. Thanks for adding hostility to IVF to your theocrat soup.

Haven't you figured it out yet? You ALWAYS have your ass handed to you when you pull your posts out of it.

This how you do it, nitwit, with f'ing facts.

Abortion Rights Victories Continue: Here Are All The Wins In Major Elections Since The Supreme Court Overturned Roe

https://www.forbes.com/sites/alisondurkee/202...267af626ad


Abortion rights supporters celebrate winning Ohio's Issue 1 ballot measure, which protects ... [+]AFP VIA GETTY IMAGES

KEY F'ing FACTS

2022 Special Elections: Abortion first emerged as a galvanizing issue for voters in Kansas’ August 2022 election, where voters in the right-leaning state shot down a ballot measure that would have paved the way for abortion to be banned in the state with 59.1% of the vote.

Abortion was also viewed as a defining issue in a New York special election in August 2022, where Democrat Pat Ryan eked out a narrow win in his congressional race after campaigning on his support for abortion rights.

2022 Midterms: Voters in California, Kentucky, Michigan, Montana and Vermont all voted in favor of abortion rights on ballot measures in the 2022 midterms (with no states voting against the procedure)— California, Michigan and Vermont’s measures explicitly preserved abortion access, while Kentucky voters rejected a constitutional amendment saying the constitution does not protect abortion rights, and Montana voters rejected a narrow proposal giving rights to fetuses who are “born alive” after failed abortions.

Democrats won key gubernatorial races in Arizona, Pennsylvania, Michigan and Wisconsin, ensuring they could veto any abortion bans passed by their states’ GOP-controlled legislatures.

Republicans also failed to get legislative supermajorities in North Carolina and Wisconsin that would have allowed them to override governors’ vetoes and ban abortion—at least temporarily, as North Carolina Republicans later ended up getting a supermajority and banning abortion after 12 weeks anyway, after state Rep. Tricia Cotham switched her party affiliation from Democrat to Republican despite campaigning on abortion rights.

2023 Elections: The most direct win for abortion rights on Tuesday was in Ohio, where voters passed a ballot measure that explicitly protected reproductive rights, ensuring abortion’s legality in the state as its Supreme Court weighed reinstating a six-week ban.

Democrats in Virginia also took control of both legislative chambers after Republicans campaigned on enacting a 15-week abortion ban—attempting to paint the proposal as a less-extreme “limit,” rather than a ban.

Kentucky Gov. Andy Beshear (D) won reelection against Republican Attorney General Daniel Cameron, who previously took his fight to defend the state’s abortion ban to the Supreme Court, after Beshear campaigned on abortion and blasted the lack of exceptions in the state’s abortion ban.

BIG NUMBER

60%. That’s the share of registered voters in Virginia who said abortion was a “very important” issue for them in the state’s election, according to a Washington Post/Schar School poll released ahead of the election in October.

WHAT TO WATCH FOR

The success of abortion on the ballot this year signals the issue is likely to continue to be a key factor in the 2024 general election. Abortion will be on the ballot in New York and Maryland—with other proposals moving forward in such states as Arizona, Florida, Nevada and Pennsylvania—with Democrats likely using it to attract supporters to the polls in the presidential election and down-ballot races.

“Abortion is the No. 1 issue in the 2024 campaign,” Illinois Gov. J.B. Pritzker (D) told the New York Times Tuesday. “If you’re not talking about protecting women’s reproductive rights as a Democrat, you’re not doing it right.”

CHIEF CRITIC

Anti-abortion rights advocates have railed against the results of Tuesday’s elections, with leading organization Susan B. Anthony Pro-Life America saying in a statement the GOP’s losses in Virginia suggest consultants in the party need to “wake up” regarding how Republicans campaign against abortion rights.

“We are deeply disappointed by last night’s results, which serve as a warning sign for the GOP heading into 2024,” president Marjorie Dannenfelser said in a statement. “Candidates must put money and messaging toward countering the Democrats’ attacks or they will lose every time.”
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Taseko Mines Earnings: Missed Estimates or Surprising Upside?

Updated Category News Views 144

Taseko Mines (AMEX:TGB) is set to drop its quarterly earnings report on February 18, 2026, and traders are already buzzing about it. The whispers in the hallways suggest a glimmer of hope, with analysts eyeing an earnings per share (EPS) of $0.08—a target that could shift market sentiments depending on how it lands. The last quarter's performance still stings; Taseko...

Continue Reading
Magnet Biomedicine Enhances Research with Simplicis's Ledger™

Updated Category News Views 173

Magnet Biomedicine Partners with Simplicis's Ledger™ Platform Magnet Biomedicine, a pioneering biotechnology firm focused on advancing molecular glue discovery, has recently chosen Simplicis's Ledger™ platform following a thorough assessment of leading alternatives. This decision reflects a commitment to enhancing research operations and optimizing compound management...

Continue Reading
Forecasting Asset Appreciation: Bitcoin and Gold's Potential Rise

Updated Category News Views 114

Understanding Market Dynamics Under Uncertain Political Landscapes In the world of finance, significant political changes can lead to substantial shifts in market dynamics. Recent insights from JPMorgan analysts suggest that a victory for Donald Trump could lead to a spike in both Bitcoin and gold prices. This projection is rooted in growing interest from retail investors...

Continue Reading
Apple and Google Forge a Powerful AI Partnership for Future

Updated Category News Views 73

Apple and Google's Exciting AI Collaboration With the excitement surrounding artificial intelligence expected to surge into 2026, tech enthusiasts and market analysts alike are keenly observing the landscape. The anticipation is mounting as companies evaluate their AI capabilities, looking to distinguish true leaders from those merely riding the wave of hype. In a...

Continue Reading
Podcasting Industry Set to Hit $114 Billion With New Trends

Updated Category News Views 241

Explosive Growth in the Podcasting Market Podcasting continues to gain massive traction, with predictions estimating the market will skyrocket from USD 31.49 billion now to an impressive USD 114.48 billion by 2030. This remarkable growth, with a compound annual growth rate (CAGR) of 29.45%, is driven by several innovative trends reshaping the media landscape....

Continue Reading